Ken James
Patrimonio netto: 7 004 $ in data 31/05/2026
Patrimonio netto: 7 004 $ in data 31/05/2026
Ken James is currently Executive Director, Head-Research & Development at Futura Medical Plc since 2016.
Formerly, Mr. James was Director at Futura Medical Developments Ltd. Mr. James was Senior Vice President-Research & Development at Glaxo SmithKline Consumer Healthcare Ltd. from 2006 to 2016.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
FUTURA MEDICAL PLC 0,14% | 31/12/2025 | 799.501 ( 0,14% ) | 7 004 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| FUTURA MEDICAL PLC | Direttore Tecnico/Scientifico/R&S | 16/11/2016 |
| Società | Posizione | Fine |
|---|---|---|
Glaxo SmithKline Consumer Healthcare Ltd.
Glaxo SmithKline Consumer Healthcare Ltd. Medical DistributorsDistribution Services Manufactures and supplies over the counter drugs | Direttore Tecnico/Scientifico/R&S | 01/02/2016 |
Futura Medical Developments Ltd.
Futura Medical Developments Ltd. BiotechnologyHealth Technology Develops biological products | Direttore/Membro del Consiglio | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 3 |
|---|---|
Futura Medical Plc
Futura Medical Plc Pharmaceuticals: OtherHealth Technology Produces pharmaceutical products | Health Technology |
Glaxo SmithKline Consumer Healthcare Ltd.
Glaxo SmithKline Consumer Healthcare Ltd. Medical DistributorsDistribution Services Manufactures and supplies over the counter drugs | Distribution Services |
Futura Medical Developments Ltd.
Futura Medical Developments Ltd. BiotechnologyHealth Technology Develops biological products | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale